$DYN
Dyne Therapeutics Inc

2021 Q4 Form 10-Q Financial Statement

#000095017021002933 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.659M $6.256M $3.840M
YoY Change 48.6% 62.92%
% of Gross Profit
Research & Development $42.30M $36.51M $9.679M
YoY Change 91.41% 277.21% 224.58%
% of Gross Profit
Depreciation & Amortization $341.0K $300.0K $200.0K
YoY Change 55.0% 50.0% 100.0%
% of Gross Profit
Operating Expenses $51.96M $42.77M $13.52M
YoY Change 81.68% 216.32% 353.39%
Operating Profit -$42.77M -$13.52M
YoY Change 216.32% 272.55%
Interest Expense $182.0K $184.0K -$130.0K
YoY Change -464.0% -241.54%
% of Operating Profit
Other Income/Expense, Net -$8.000K $184.0K -$400.0K
YoY Change -146.0% -82.16%
Pretax Income -$51.79M -$42.58M -$13.92M
YoY Change 80.75% 205.91%
Income Tax
% Of Pretax Income
Net Earnings -$51.79M -$42.58M -$13.92M
YoY Change 80.75% 205.91% 137.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.83
Diluted Earnings Per Share -$1.005M -$829.7K -$319.3K
COMMON SHARES
Basic Shares Outstanding 51.53M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $376.6M $407.5M $379.6M
YoY Change 9.05% 7.36%
Cash & Equivalents $200.8M $229.0M $379.6M
Short-Term Investments $175.7M $178.5M
Other Short-Term Assets $5.821M $17.13M $200.0K
YoY Change 53.18% 8466.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $382.4M $424.7M $379.8M
YoY Change 9.54% 11.8%
LONG-TERM ASSETS
Property, Plant & Equipment $4.678M $2.988M $1.441M
YoY Change 140.39% 107.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.311M $2.308M $191.0K
YoY Change 0.48% 1108.38%
Total Long-Term Assets $43.27M $42.22M $1.632M
YoY Change 918.86% 2487.19%
TOTAL ASSETS
Total Short-Term Assets $382.4M $424.7M $379.8M
Total Long-Term Assets $43.27M $42.22M $1.632M
Total Assets $425.7M $466.9M $381.5M
YoY Change 20.47% 22.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.031M $7.088M $1.488M
YoY Change 17.18% 376.34%
Accrued Expenses $24.69M $16.26M $2.700M
YoY Change 229.23% 502.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $28.72M $23.35M $4.678M
YoY Change 161.9% 399.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $9.936M
YoY Change -100.0%
Other Long-Term Liabilities $28.74M $29.41M $0.00
YoY Change
Total Long-Term Liabilities $28.74M $29.41M $9.936M
YoY Change 196.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.72M $23.35M $4.678M
Total Long-Term Liabilities $28.74M $29.41M $9.936M
Total Liabilities $57.47M $52.76M $14.61M
YoY Change 423.99% 261.04%
SHAREHOLDERS EQUITY
Retained Earnings -$228.5M -$176.7M -$50.53M
YoY Change 188.54% 249.64%
Common Stock $6.000K $6.000K
YoY Change 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $368.2M $414.1M $366.8M
YoY Change
Total Liabilities & Shareholders Equity $425.7M $466.9M $381.5M
YoY Change 20.47% 22.39%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$51.79M -$42.58M -$13.92M
YoY Change 80.75% 205.91% 137.1%
Depreciation, Depletion And Amortization $341.0K $300.0K $200.0K
YoY Change 55.0% 50.0% 100.0%
Cash From Operating Activities -$28.07M -$26.95M -$11.87M
YoY Change 40.06% 127.06%
INVESTING ACTIVITIES
Capital Expenditures -$1.990M -$881.0K -$160.0K
YoY Change 176.39% 450.63%
Acquisitions
YoY Change
Other Investing Activities $1.755M -$1.967M
YoY Change -103.94%
Cash From Investing Activities -$235.0K -$2.848M -$160.0K
YoY Change -99.48% 1680.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 89.00K 457.0K 380.0M
YoY Change -100.8% -99.88%
NET CHANGE
Cash From Operating Activities -28.07M -26.95M -11.87M
Cash From Investing Activities -235.0K -2.848M -160.0K
Cash From Financing Activities 89.00K 457.0K 380.0M
Net Change In Cash -28.21M -29.34M 367.9M
YoY Change -63.09% -107.98%
FREE CASH FLOW
Cash From Operating Activities -$28.07M -$26.95M -$11.87M
Capital Expenditures -$1.990M -$881.0K -$160.0K
Free Cash Flow -$26.08M -$26.07M -$11.71M
YoY Change 34.98% 122.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2021Q3 us-gaap Interest Expense Other
InterestExpenseOther
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dyn Changes In Success Fee Obligation
ChangesInSuccessFeeObligation
dei Entity Central Index Key
EntityCentralIndexKey
0001818794
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 dyn Changes In Success Fee Obligation
ChangesInSuccessFeeObligation
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q3 us-gaap Interest Income Other
InterestIncomeOther
us-gaap Interest Expense Other
InterestExpenseOther
us-gaap Short Term Lease Cost
ShortTermLeaseCost
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39509
dei Entity Registrant Name
EntityRegistrantName
Dyne Therapeutics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4883909
dei Entity Address Address Line1
EntityAddressAddressLine1
830 Winter Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Waltham
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02451
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
786-8230
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
DYN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51528469
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
229042000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300852000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
178481000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
44462000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17132000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3773000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
424655000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
349087000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2988000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1946000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36927000
CY2021Q3 dyn Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
2308000
CY2020Q4 dyn Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
2301000
CY2021Q3 us-gaap Assets
Assets
466878000
CY2020Q4 us-gaap Assets
Assets
353334000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7088000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3440000
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
11674000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7527000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4589000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
23351000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10967000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29411000
CY2021Q3 us-gaap Liabilities
Liabilities
52762000
CY2020Q4 us-gaap Liabilities
Liabilities
10967000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51607908
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45446903
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51483643
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45076574
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
6000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
590832000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
421572000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-176688000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79183000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
414116000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
342367000
us-gaap Interest Income Other
InterestIncomeOther
24000
CY2020Q3 us-gaap Interest Expense Other
InterestExpenseOther
130000
us-gaap Interest Expense Other
InterestExpenseOther
315000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-42582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13920000
us-gaap Net Income Loss
NetIncomeLoss
-97505000
us-gaap Net Income Loss
NetIncomeLoss
-30788000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
466878000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
353334000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36510000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9679000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
79007000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23102000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6256000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3841000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19058000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6945000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
42766000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
13520000
us-gaap Operating Expenses
OperatingExpenses
98065000
us-gaap Operating Expenses
OperatingExpenses
30047000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-42766000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13520000
us-gaap Operating Income Loss
OperatingIncomeLoss
-98065000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30047000
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
184000
us-gaap Interest Income Other
InterestIncomeOther
560000
CY2020Q3 dyn Changes In Success Fee Obligation
ChangesInSuccessFeeObligation
270000
dyn Changes In Success Fee Obligation
ChangesInSuccessFeeObligation
450000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
184000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-400000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
560000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-741000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-42582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13920000
us-gaap Net Income Loss
NetIncomeLoss
-97505000
us-gaap Net Income Loss
NetIncomeLoss
-30788000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.92
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.51
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51320940
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6920008
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50676668
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4100504
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13920000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-97512000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42575000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30788000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
342367000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
157237000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3652000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-41000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-24968000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
478260000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4239000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
27000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-29955000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
452596000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
457000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3638000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-42582000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
414116000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
14036000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
66000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7886000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
8188000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8982000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-719000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
246411000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
24000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2235000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13920000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
366845000
us-gaap Profit Loss
ProfitLoss
-97505000
us-gaap Profit Loss
ProfitLoss
-30788000
us-gaap Share Based Compensation
ShareBasedCompensation
11529000
us-gaap Share Based Compensation
ShareBasedCompensation
2376000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
747000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
483000
dyn Non Cash Lease Expense
NonCashLeaseExpense
-28000
dyn Amortization Accretion Of Premium Discount On Marketable Securities
AmortizationAccretionOfPremiumDiscountOnMarketableSecurities
1843000
dyn Changes In Success Fee Obligation
ChangesInSuccessFeeObligation
450000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12816000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
107000
dyn Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
2940000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
7675000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1114000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-91495000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26472000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1628000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
438000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
208207000
dyn Maturities Of Marketable Securities
MaturitiesOfMarketableSecurities
72178000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-137657000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-438000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
247454000
dyn Proceeds From Issuance Follow On Public Offering
ProceedsFromIssuanceFollowOnPublicOffering
157237000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
9936000
dyn Payments For Settlement Of Success Fee Obligation
PaymentsForSettlementOfSuccessFeeObligation
450000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
134920000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
495000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
157732000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
391884000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71420000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
364974000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
303153000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14632000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
231733000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
379606000
dyn Cash Paid For Interest And Income Taxes
CashPaidForInterestAndIncomeTaxes
311000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
161000
dyn Right Of Use Assets Acquired Under Operating Leases
RightOfUseAssetsAcquiredUnderOperatingLeases
33799000
dyn Issuance Costs From Convertible Preferred Stock Included In Accounts Payable Or Accrued Expenses
IssuanceCostsFromConvertiblePreferredStockIncludedInAccountsPayableOrAccruedExpenses
0
dyn Issuance Costs From Convertible Preferred Stock Included In Accounts Payable Or Accrued Expenses
IssuanceCostsFromConvertiblePreferredStockIncludedInAccountsPayableOrAccruedExpenses
134000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
162215000
dyn Public Offering Costs Included In Accounts Payable Or Accrued Expenses
PublicOfferingCostsIncludedInAccountsPayableOrAccruedExpenses
1043000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2017-12-01
dyn Lease Term Description
LeaseTermDescription
The Company classifies leases with a term greater than one year as either operating or finance leases at the lease commencement date and records a right-of-use assets and current and non-current lease liabilities, as applicable on the balance sheet.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
229042000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300852000
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
383000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2308000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2301000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
231733000
dyn Cash And Cash Equivalents Maturity Period
CashAndCashEquivalentsMaturityPeriod
P90D
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
2700000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
2300000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
303153000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
178515000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
16000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
50000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
178481000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
44489000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
27000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
44462000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7325672
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.73
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
CY2021Q3 dyn Fair Value Assets Transfers Amount
FairValueAssetsTransfersAmount
0
CY2020Q4 dyn Fair Value Assets Transfers Amount
FairValueAssetsTransfersAmount
0
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
131877000
CY2021Q3 dyn Available For Sale Debt Securities Maturing In One Year Through Two Years
AvailableForSaleDebtSecuritiesMaturingInOneYearThroughTwoYears
46604000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
178481000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4730000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2941000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1742000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
995000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2988000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1946000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
300000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
700000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0167
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2693000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2105000
CY2021Q3 dyn Accrued Consulting Services Current
AccruedConsultingServicesCurrent
694000
CY2020Q4 dyn Accrued Consulting Services Current
AccruedConsultingServicesCurrent
263000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
136000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
325000
CY2021Q3 dyn Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
8151000
CY2020Q4 dyn Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
4782000
CY2020Q4 dyn Accrued Facility Costs Current
AccruedFacilityCostsCurrent
52000
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
11674000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7527000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0082
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0117
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0031
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6421589
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.97
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y6M
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
90112000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1160176
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
18.15
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
120930
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
135163
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.83
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.27
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
60678000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1567826
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y3M18D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16944000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6932411
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.73
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
57499000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3638000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2235000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11529000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2376000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-42582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13920000
us-gaap Net Income Loss
NetIncomeLoss
-97505000
us-gaap Net Income Loss
NetIncomeLoss
-30788000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51320940
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6920008
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50676668
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4100504
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.92
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.51
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8008689
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7153784
dyn Lease Executed Date
LeaseExecutedDate
2019-07-01
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2021-12-31
CY2020Q4 dyn Facility Additional Area Leased
FacilityAdditionalAreaLeased
68187
CY2020Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P8Y6M
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Company’s obligation for the payment of base rent for the Premises begins in April 2022, and will be $0.4 million per month, increasing up to $0.5 million during the term of the Lease. The Company has two options to extend the term of the Lease, each for a period of an additional five years.
CY2020Q4 dyn Operating Lease Monthly Rent Expense
OperatingLeaseMonthlyRentExpense
400000
CY2020Q4 dyn Operating Lease Increase In Monthly Rent Expense
OperatingLeaseIncreaseInMonthlyRentExpense
500000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has two options to extend the term of the Lease, each for a period of an additional five years
CY2020Q4 dyn Operating Lease Period Of Extension
OperatingLeasePeriodOfExtension
P5Y
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
600000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
189000
us-gaap Operating Lease Cost
OperatingLeaseCost
569000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
135000
us-gaap Variable Lease Cost
VariableLeaseCost
381000
CY2021Q3 us-gaap Lease Cost
LeaseCost
324000
us-gaap Lease Cost
LeaseCost
950000
us-gaap Operating Lease Payments
OperatingLeasePayments
597000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0579
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2391000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3452000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4706000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4847000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4993000
CY2021Q3 dyn Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
22930000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
43319000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9319000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
34000000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4589000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29411000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
34000000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
800000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3452000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4706000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4847000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4993000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
22930000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
41728000

Files In Submission

Name View Source Status
0000950170-21-002933-index-headers.html Edgar Link pending
0000950170-21-002933-index.html Edgar Link pending
0000950170-21-002933.txt Edgar Link pending
0000950170-21-002933-xbrl.zip Edgar Link pending
dyn-20210930.htm Edgar Link pending
dyn-20210930.xsd Edgar Link pending
dyn-20210930_cal.xml Edgar Link unprocessable
dyn-20210930_def.xml Edgar Link unprocessable
dyn-20210930_htm.xml Edgar Link completed
dyn-20210930_lab.xml Edgar Link unprocessable
dyn-20210930_pre.xml Edgar Link unprocessable
dyn-ex31_1.htm Edgar Link pending
dyn-ex31_2.htm Edgar Link pending
dyn-ex32_1.htm Edgar Link pending
dyn-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending